No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Scholar Rock Highlights Upcoming Priorities For 2025; Says BLA And MAA Submission For Apitegromab In SMA On Track For Q1
Express News | Scholar Rock Holding Corp - Initiating Phase 2 Opal Trial in Sma Patients Under Two Years Old in Mid- 2025
Express News | Scholar Rock Holding Corp -Filing of Ind Application for Srk-439 on Track for 3Q 2025
Express News | Scholar Rock Highlights 2025 Strategic Priorities
SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?